Skip to main content
OpenTrials
Completed

NCT Number: NCT01731496

The Efficacy of Reminders to Complete HPV Series

The human papillomavirus (HPV) vaccine is routinely recommended for both adolescent girls and boys starting at age 11, although it can be offered as young as 9 years of age. This is a 3-dose series and many adolescents do not complete it after getting the first dose. This study will study how effective it will be to send reminders to parents to schedule an appointment when their child is due for the next dose of HPV. Parents can chose whether they would like a phone call or text message reminder. This study will determine if the reminders work, and if one method is better than another (phone message vs. text message).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Completion of Three Dose Series of HPV Improvement in Vaccine Intervals Between HPV Doses

Age range

10 year–21 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Culver Medical Group, Rochester, New York, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Parents of adolescents aged 10 - 17 who have had at least 1 dose of HPV
  • Patients aged 18 - 21 who have had at least 1 dose of HPV

Exclusion criteria

Treatment and study plan

Telephone Reminder

Other

One week prior to when a child is due for either their 2nd or 3rd HPV vaccine, their parent will receive a telephone reminder to call to make an appointment to receive their next dose. A total of 3 reminders will be sent.

Text Message Reminder

Other

One week prior to when a child is due for either their 2nd or 3rd HPV vaccine, their parent will receive a text message reminder to call to make an appointment to receive their next dose. A total of 3 reminders will be sent.

Primary outcomes

  1. HPV completion rate

    Time frame: One Year

    Post intervention HPV vaccination rates will be summarized by intervention group with frequencies and proportions, and will be compared between groups using chi square or Fisher's exact test as appropriate

Secondary outcomes

  1. HPV Dosing Intervals

    Time frame: One Year

    Dosing intervals will be summarized by group with mean, median, standard deviation and will be compared between groups using a two sample t-test.

Sponsors and collaborators

Lead sponsor

University of Rochester

Other

Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

Registry information

Official study title

Improving Communication and Health for Adolescents With Technology - Implementation of Immunization Strategy

Acronym: ICHAT

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Nov 21, 2012
Registry last updated
Feb 6, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.